Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments

BACKGROUND: Daptomycin and ceftaroline (DAP-CPT) have been used for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), but have rarely been compared with other therapies. This study provides an exploratory analysis of patients placed on DAP-CPT vs standard of care (SOC) for M...

Descripción completa

Detalles Bibliográficos
Autores principales: McCreary, Erin K, Kullar, Ravina, Geriak, Matthew, Zasowski, Evan J, Rizvi, Khulood, Schulz, Lucas T, Ouellette, Krista, Vasina, Logan, Haddad, Fadi, Rybak, Michael J, Zervos, Marcus J, Sakoulas, George, Rose, Warren E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951465/
https://www.ncbi.nlm.nih.gov/pubmed/31938716
http://dx.doi.org/10.1093/ofid/ofz538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951465/
https://www.ncbi.nlm.nih.gov/pubmed/31938716
http://dx.doi.org/10.1093/ofid/ofz538

Ejemplares similares